Abraham JD, Promé S, Salvetat N, Rubrecht L, Cobo S, du Paty E, Galéa P, Mathieu-Dupas E, Ranaldi S, Caillava C, Crémer GA, Rieunier F, Robert P, Molina F, Laune D, Checler F, Fareh J. Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease. Transl Psychiatry. 2013 Jul 16;3:e281. PubMed.
AlzBiomarker Database
Meta-Analysis
- AD vs CTRL : Aβ40 (CSF)
- CTRL vs AD : Aβ40 (CSF)
- AD vs CTRL : Aβ42 (CSF)
- CTRL vs AD : Aβ42 (CSF)
- AD vs CTRL : tau-p181 (CSF)
- CTRL vs AD : tau-p181 (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
Curated Study Data
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
Aβ40 (CSF) |
AD (23) |
133.69 ± 56.77 pg/mL |
xMAP; Other/Not Specified; In-house |
McKhann et al., 1984 |
Aβ40 (CSF) |
CTRL- CNC (21) |
163.56 ± 39.35 pg/mL |
xMAP; Other/Not Specified; In-house |
|
Aβ42 (CSF) |
AD (23) |
356.2 ± 107.48 pg/mL |
xMAP; AlzBio3; Innogenetics |
McKhann et al., 1984 |
Aβ42 (CSF) |
CTRL- CNC (21) |
557.48 ± 88.45 pg/mL |
xMAP; AlzBio3; Innogenetics |
|
tau-p181 (CSF) |
AD (23) |
56.37 ± 35.65 pg/mL |
xMAP; AlzBio3; Innogenetics |
McKhann et al., 1984 |
tau-p181 (CSF) |
CTRL- CNC (21) |
27.61 ± 7.21 pg/mL |
xMAP; AlzBio3; Innogenetics |
|
tau-total (CSF) |
AD (23) |
145.4 ± 89.1 pg/mL |
xMAP; AlzBio3; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
CTRL- CNC (21) |
54.72 ± 20.13 pg/mL |
xMAP; AlzBio3; Innogenetics |
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.